Mackay Shields LLC’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-204,571
| Closed | -$9.06M | – | 309 |
|
|
2022
Q1 | $9.06M | Sell |
204,571
-8,054
| -4% | -$357K | 0.08% | 235 |
|
|
2021
Q4 | $9.03M | Sell |
212,625
-4,470
| -2% | -$190K | 0.08% | 248 |
|
|
2021
Q3 | $9.42M | Sell |
217,095
-6,289
| -3% | -$273K | 0.09% | 221 |
|
|
2021
Q2 | $9.55M | Sell |
223,384
-26,666
| -11% | -$1.14M | 0.09% | 219 |
|
|
2021
Q1 | $9.67M | Sell |
250,050
-23,192
| -8% | -$896K | 0.07% | 294 |
|
|
2020
Q4 | $9.82M | Buy |
273,242
+236
| +0.1% | +$8.48K | 0.07% | 312 |
|
|
2020
Q3 | $10.4M | Buy |
273,006
+17,329
| +7% | +$662K | 0.07% | 297 |
|
|
2020
Q2 | $8.98M | Buy |
255,677
+42,191
| +20% | +$1.48M | 0.07% | 302 |
|
|
2020
Q1 | $6.97M | Sell |
213,486
-1,471
| -0.7% | -$48K | 0.06% | 328 |
|
|
2019
Q4 | $9.72M | Sell |
214,957
-13,679
| -6% | -$619K | 0.07% | 331 |
|
|
2019
Q3 | $9.3M | Buy |
228,636
+2,198
| +1% | +$89.4K | 0.06% | 352 |
|
|
2019
Q2 | $9.73M | Sell |
226,438
-18,566
| -8% | -$798K | 0.07% | 345 |
|
|
2019
Q1 | $9.4M | Buy |
245,004
+1,128
| +0.5% | +$43.3K | 0.07% | 330 |
|
|
2018
Q4 | $8.62M | Sell |
243,876
-11,247
| -4% | -$397K | 0.07% | 337 |
|
|
2018
Q3 | $9.82M | Sell |
255,123
-20,645
| -7% | -$795K | 0.08% | 308 |
|
|
2018
Q2 | $9.02M | Buy |
275,768
+44,631
| +19% | +$1.46M | 0.06% | 359 |
|
|
2018
Q1 | $6.32M | Buy |
+231,137
| New | +$6.32M | 0.04% | 456 |
|